Release Date: 27/04/12 12:16 Summary: Cancellation of Shares under Buyback Price Sensitive: No Download Document 253.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%